RGC

Regencell Bioscience Holdings Ltd RGC

NasdaqMid CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$8.56M total
GEODE CAPITAL MANAGEMENT, LLC
$2.57M+1.6%
Alyeska Investment Group, L.P.
$2.54MNew
Legal & General Group Plc
$779.0K+1192.5%
JANE STREET GROUP, LLC
$598.9KNew
XTX Topco Ltd
$365.8KNew
Amundi
$287.2K+448.7%
UBS Group AG
$263.1K+80.9%
Quadrature Capital Ltd
$254.3KNew
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$140.9KNew
Squarepoint Ops LLC
$134.2K-17.2%
FOX RUN MANAGEMENT, L.L.C.
$126.0KNew
CIBC Asset Management Inc
$93.1KNew
BANK OF AMERICA CORP /DE/
$91.3K-12.7%
TWO SIGMA INVESTMENTS, LP
$87.7KNew
Vident Advisory, LLC
$68.2K-62.2%
MORGAN STANLEY
$30.8K-74.8%
BlackRock, Inc.
$30.0K-0.6%
State of Wyoming
$24.8KNew
Federation des caisses Desjardins du Quebec
$17.1K+25.6%
Aquatic Capital Management LLC
$12.5KNew
CITIGROUP INC
$11.2KNew
SIMPLEX TRADING, LLC
$10.5KNew
GROUP ONE TRADING, L.P.
$5.8K+169.2%
Russell Investments Group, Ltd.
$4.6K0.0%
OSAIC HOLDINGS, INC.
$3.9K+182.8%
See all 35 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

FY 2026
EDGAR

EPS (Diluted)

FY 2026
EDGAR

ROIC

FY 2026
EDGAR

Loading ratio trend…

RGC insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

Congress trading in RGC

2 transactions in RGC reported by 1 member of Congress under the STOCK Act, most recent trade Dec 8, 2017. Reported transactions, not recommendations.

All Congress stock trades →

About Regencell Bioscience Holdings Ltd (RGC): stock profile, AI score and financials

Regencell Bioscience Holdings Ltd (RGC) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. RGC is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of RGC by reported 13-F value include GEODE CAPITAL MANAGEMENT, Alyeska Investment Group, L.P., Legal & General Group Plc, based on the most recent SEC filings. RGC trades on the Nasdaq exchange and files with the SEC under CIK 1829667. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate RGC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Regencell Bioscience Holdings Ltd directly from SEC EDGAR.

SEC EDGAR: CIK 1829667 →